Evidence map›Paper›PMID 17203532›Full record

ArticleWorld journal of gastroenterology2006

Novel MLH1 frameshift mutation in an extended hereditary nonpolyposis colorectal cancer family.

Tanya-Kirilova Kadiyska, Radka-Petrova Kaneva, Dimitar-Georgiev Nedin, Alexandrina-Borisova Alexandrova, Antonina-Todorova Gegova, Stoyan-Ganchev Lalchev, Tatyana Christova, Vanio-Ivanov Mitev, Juergen Horst, Nadja Bogdanova and 1 more

Open access · hybridAbstract read
In one paragraph

Article in World journal of gastroenterology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Tanya-Kirilova KadiyskaLaboratory of Molecular Pathology, University Hospital of Obstetrics and Gynecology, 2 Zdrave str., Sofia-1431, Bulgaria. alextanya@excite.com
Radka-Petrova Kaneva
Dimitar-Georgiev Nedin
Alexandrina-Borisova Alexandrova
Antonina-Todorova Gegova
Stoyan-Ganchev Lalchev
Tatyana Christova
Vanio-Ivanov Mitev
Juergen Horst
Nadja Bogdanova
Ivo-Marinov Kremensky
Medical University of Sofia · BG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo present novel frameshift mutation c.31delC [p.L11X] in the MLH1 gene identified in an extended Bulgarian hereditary non-polyposis colorectal cancer (HNPCC) family and to analyze the molecular and clinical findings within the pedigree concerning the proposal of adequate individual prophylactic strategy for all mutation carriers.

methodsThe pedigree of the family consists of 42 members in four generations. Search for mutations in the MLH1 and hMSH2 genes was performed in the proband. After PCR amplification of all exons including flanking intronic regions, amplicons were directly sequenced.

resultsThe mutation was found in nine from the thirteen pedigree members who signed informed consent to participate in the study. In three adenocarcinomas, microsatellite instability and lack of the MLH1 protein expression were detected. The only one tubulovillous adenoma analyzed was microsatellite stable and the MLH1 protein showed an intact staining.

conclusionThe newly described mutation c.31delC is HNPCC causative. Besides the typical clinical features of the syndrome, we found a specific pathologic manifestation such as moderate to high differentiated adenocarcinomas of the colon. One of the mutation carriers developed a benign giant cell soft tissue tumor. The primary tumor localizations were frequently extracolonic and detailed yearly gastrointestinal and gynecological examinations have been proposed to the mutation carriers. We emphasize the importance of including the HNPCC genetic counseling and testing as well in the following surveillance of all patients at risk in the services covered by the health insurance in Bulgaria.

Indexed as

PedigreeAdaptor Proteins, Signal TransducingAdenocarcinomaAdultAgedAged, 80 and overBulgariaCarrier ProteinsColorectal Neoplasms, Hereditary NonpolyposisDNA, NeoplasmFemaleFrameshift MutationGene Expression Regulation, NeoplasticGenetic CounselingHumansMaleAdaptor Proteins, Signal TransducingCarrier ProteinsDNA, NeoplasmMLH1 protein, humanMSH2 protein, humanMutL Protein Homolog 1MutS Homolog 2 ProteinNuclear Proteins

Identifiers

PMID17203532
PMCPMC4087554
OpenAlexW871729919

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.